Modular Medical Faces Imminent Liquidity Crisis, Warns of Going Concern, and Pursues Reverse Split Amidst Deeply Dilutive Financings

summarizeSummary

Modular Medical, Inc. disclosed an immediate liquidity crisis, stating it lacks funds for the next 30 days, and reiterated substantial doubt about its ability to continue as a going concern, alongside a Nasdaq delisting threat and recent dilutive capital raises.

check_boxKey Events

• Immediate Liquidity Crisis and Going Concern Warning

  The company explicitly stated it currently lacks sufficient liquidity to fund its operations for the next 30 days and that conditions raise substantial doubt about its ability to continue as a going concern within one year. Its independent auditor also expressed substantial doubt.

• Nasdaq Delisting Threat and Reverse Stock Split Plan

  Modular Medical received a 180-day extension until June 29, 2026, to regain Nasdaq's $1 minimum bid price compliance. Shareholders approved a reverse stock split on January 23, 2026, as a measure to address this, following a prior DEF 14A filing on January 8, 2026, seeking approval for the split.

• Significant Dilutive Capital Raises

  During the nine months ended December 31, 2025, the company raised approximately $4.8 million from a public offering of common stock and warrants (effective price $0.38/share and $0.01/warrant), $4.0 million from a warrant inducement offering at a reduced exercise price of $0.68/share, and $1.9 million from at-the-market (ATM) sales. These financings were highly dilutive and indicate financial distress.

• Increased Operating Losses and Cash Burn

  Net loss for the nine months ended December 31, 2025, significantly increased to $21.852 million from $13.897 million in the prior year. Cash used in operating activities also rose to $17.938 million from $11.410 million in the comparable period.

auto_awesomeAnalysis

This 10-Q filing reveals a critical financial situation for Modular Medical, Inc., explicitly stating the company lacks sufficient liquidity to fund operations for the next 30 days and raising substantial doubt about its ability to continue as a going concern. This immediate liquidity crisis, coupled with a Nasdaq delisting threat and deeply dilutive capital raises at significant discounts, presents an extremely negative outlook for investors. While the company is advancing its Pivot pump product, the severe financial instability overshadows any operational progress. The identified material weakness in internal controls further compounds the risk. Investors should be aware of the high risk of further dilution, potential delisting, or even cessation of operations if additional capital cannot be secured on acceptable terms.